Published in Circulation on September 02, 1997
Upregulation of Nox4 by TGF{beta}1 oxidizes SERCA and inhibits NO in arterial smooth muscle of the prediabetic Zucker rat. Circ Res (2010) 1.17
Influence of diabetes mellitus on heart failure risk and outcome. Cardiovasc Diabetol (2003) 1.12
High prevalence of undiagnosed impaired glucose regulation and diabetes mellitus in patients scheduled for an elective coronary angiography. Clin Res Cardiol (2006) 0.97
Pathobiological role of advanced glycation endproducts via mitogen-activated protein kinase dependent pathway in the diabetic vasculopathy. Exp Mol Med (2008) 0.92
Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting. Rev Endocr Metab Disord (2010) 0.90
How to revascularize patients with diabetes mellitus: bypass or stents and drugs? Clin Res Cardiol (2006) 0.87
Serum levels of advanced glycation end products are associated with in-stent restenosis in diabetic patients. Yonsei Med J (2005) 0.85
Vascular restoration therapy and bioresorbable vascular scaffold. Regen Biomater (2014) 0.84
Long term outcome after coronary stent implantation: a 10 year single centre experience of 1000 patients. Heart (1999) 0.82
Risk factors for the development of restenosis following stent implantation of venous bypass grafts. Heart (2001) 0.82
Sirolimus eluting stent (Cypher) in patients with diabetes mellitus: results from the German Cypher Stent Registry. Clin Res Cardiol (2007) 0.81
Influence of the angiotensin converting enzyme insertion or deletion genetic variant and coronary restenosis risk: evidence based on 11,193 subjects. PLoS One (2013) 0.80
Favorable Outcomes after Implantation of Biodegradable Polymer Coated Sirolimus-Eluting Stents in Diabetic Population: Results from INDOLIMUS-G Diabetic Registry. Int J Vasc Med (2015) 0.78
TP53 haplotype-based analysis and incidence of post-angioplasty restenosis. Hum Genet (2004) 0.77
[Update on diabetic macroangiopathy]. Pathologe (2012) 0.76
Does lipoprotein (a) level have a predictive value in restenosis after coronary stenting? Int J Prev Med (2011) 0.75
Long-term follow-up of coronary angioplasty in patients with diabetes compared with nondiabetics. Neth Heart J (2004) 0.75
Role of drug eluting stents in diabetic patients. Heart (2006) 0.75
Does stenting prevent diabetic arterial shrinkage after percutaneous coronary revascularization? Circulation (1997) 0.75
Is surgery still the preferred option for coronary revascularisation in diabetics with multivessel coronary disease? Heart (2002) 0.75
Long-term clinical outcome of ST-segment elevation myocardial infarction patients with and without diabetes mellitus in the Zwolle trial. Neth Heart J (2003) 0.75
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet (2001) 8.54
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest (1998) 5.95
Angiographic follow-up after placement of a self-expanding coronary-artery stent. N Engl J Med (1991) 2.97
Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomised, double-blind, placebo-controlled trial. Lancet (2001) 2.70
Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation (1999) 2.59
Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. J Am Coll Cardiol (1998) 2.27
Patency of percutaneous transluminal coronary angioplasty sites at 6-month angiographic follow-up: A key determinant of survival in diabetics after coronary balloon angioplasty. Circulation (2001) 2.26
The human G-protein beta3 subunit C825T polymorphism is associated with coronary artery vasoconstriction. Eur Heart J (2001) 2.08
Coronary angioscopic findings in the infarct-related vessel within 1 month of acute myocardial infarction: natural history and the effect of thrombolysis. Circulation (1998) 2.07
Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation (1995) 2.07
Role of the polyadenylate segment in the translation of globin messenger RNA in Xenopus oocytes. Proc Natl Acad Sci U S A (1974) 2.05
Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation (1995) 1.92
Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization. Eur Heart J (2005) 1.83
Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation (1982) 1.62
The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis. Eur Heart J (2002) 1.58
Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab Invest (1996) 1.57
D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation (1997) 1.55
Absence of polyadenylate segment in globin messenger RNA accelerates its degradation in Xenopus oocytes. Proc Natl Acad Sci U S A (1975) 1.51
[Treatment of pulmonary lymphangioleiomyomatosis using a GnRH agonist]. Rev Mal Respir (1996) 1.48
Combined antiplatelet therapy with ticlopidine and aspirin. A simplified approach to intracoronary stent management. Eur Heart J (1996) 1.47
Cardiac valve papillary fibroelastomas: clinical, histological and immunohistochemical studies and a physiopathogenic hypothesis. J Heart Valve Dis (2000) 1.46
Influence of late reopening of the infarct-related artery on left ventricular remodelling after myocardial infarction. IRIS Study Group. Eur Heart J (1997) 1.45
Percutaneous aspiration of a coronary thrombus. Cathet Cardiovasc Diagn (1989) 1.44
Hypersensitivity of human coronary segments to ergonovine 6 months after injury by coronary angioplasty: a quantitative angiographic study in consecutive patients undergoing single-vessel angioplasty. Eur Heart J (1996) 1.43
Restenosis after coronary angioplasty for rapidly progressive coronary stenosis. Eur Heart J (1996) 1.41
The scourge of coronary disease in diabetic patients: will antibiotics sweeten the pill? Eur Heart J (2002) 1.41
Morphological changes after percutaneous transluminal coronary angioplasty of unstable plaques. Insights from serial angioscopic follow-up. Eur Heart J (1996) 1.40
Readenylation of polyadenylate-free globin messenger RNA restores its stability in vivo. Eur J Biochem (1975) 1.40
Effects of coronary stenting on restenosis and occlusion after angioplasty of the culprit vessel in patients with recent myocardial infarction. Circulation (1997) 1.38
Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study. Circulation (1998) 1.37
Interventional cardiology in Europe 1995. Working Group Coronary Circulation of the European Society of Cardiology. Eur Heart J (1999) 1.36
Functional stabilisation of HeLa cell histone messenger RNAs injected into Xenopus oocytes by 3'-OH polyadenylation. Nature (1978) 1.26
Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines. Circulation (1997) 1.21
Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol (1998) 1.17
Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up. Eur Heart J (2009) 1.15
Periodontal pathogens in atheromatous plaques isolated from patients with chronic periodontitis. J Periodontal Res (2006) 1.14
Complete denervation of the heart (autotransplantation) for treatment of severe, refractory coronary spasm. Am J Cardiol (1981) 1.10
Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP). J Med Genet (2004) 1.09
Frog oocytes synthesize and completely process the precursor polypeptide to virion structural proteins after microinjection of avian myeloblastosis virus RNA. Proc Natl Acad Sci U S A (1977) 1.08
The efficacy of Liv-52 on liver cirrhotic patients: a randomized, double-blind, placebo-controlled first approach. Phytomedicine (2005) 1.07
The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction. J Am Coll Cardiol (1997) 1.07
Coronary arteriography in acute transmural myocardial infarction. Am Heart J (1979) 1.05
Heparin-coated Wiktor stents in human coronary arteries (MENTOR trial). MENTOR Trial Investigators. Am J Cardiol (2000) 1.04
Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders. Am J Hum Genet (1998) 1.01
The European registry of cardiac catheter interventions 1996. Eur Heart J (2001) 1.00
Hereditary phaeochromocytomas and paragangliomas: a study of five susceptibility genes. J Med Genet (2003) 0.98
Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab (2001) 0.96
A novel 9-base pair duplication in RET exon 8 in familial medullary thyroid carcinoma. J Clin Endocrinol Metab (1999) 0.95
Coronary sinus blood flow at rest and during isometric exercise in patients with aortic valve disease. Mechanism of angina pectoris in presence of normal coronary arteries. Am J Cardiol (1981) 0.95
Translation of mouse interferon mRNA in Xenopus laevis oocytes and in rabbit reticulocyte lysates. Biochem Biophys Res Commun (1978) 0.93
In vivo aminoacylation and 'processing' of turnip yellow mosaic virus RNA in Xenopus laevis oocytes. Nature (1978) 0.93
Relative risk analysis of angiographic predictors of restenosis within the coronary Wallstent. Circulation (1991) 0.93
Left ventricular systolic and diastolic function during acute coronary artery balloon occlusion in humans. J Am Coll Cardiol (1988) 0.92
Time course of increased cellular proliferation in collateral arteries after administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency. Am J Pathol (1995) 0.92
Response of human coronary arteries to serotonin after injury by coronary angioplasty. Circulation (1993) 0.92
Mechanisms and prevention of restenosis: from experimental models to clinical practice. Cardiovasc Res (1996) 0.92
Six-month angiographic outcome after successful repeat percutaneous intervention for in-stent restenosis. Circulation (1998) 0.91
Long-term oral administration of L-arginine reduces intimal thickening and enhances neoendothelium-dependent acetylcholine-induced relaxation after arterial injury. Circulation (1994) 0.91
Restenosis after coronary angioplasty. Eur Heart J (1995) 0.91